Company
Drugs Made In America Acquisition Corp. (DMAA)
Standardized SEC financial data for Drugs Made In America Acquisition Corp. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0002028614 · NASDAQ · Blank Checks.
Return on equity
-81.8%
Free cash flow
-$539K
Current ratio
0.03×
Income statement
| USD | FY2025 |
|---|---|
| SG&A expense | $2.8M |
| Operating income | -$2.8M |
| Net income | $5.9M |
Standardized from Drugs Made In America Acquisition Corp.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2024 | FY2025 |
|---|---|---|
| Cash & equivalents | $1K | $6K |
| Total current assets | $5K | $12K |
| Total assets | $551K | $239.9M |
| Total current liabilities | $796K |
Cash flow
| USD | FY2025 |
|---|---|
| Operating cash flow | -$539K |
| Investing cash flow | -$231.2M |
| Financing cash flow | $231.7M |
| Dividends paid | $0 |
Get DMAA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/DMAA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/DMAA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"